Alexandria Real Estate Equities, Inc. (NYSE:ARE – Free Report) – Research analysts at Zacks Research reduced their Q3 2025 earnings per share estimates for shares of Alexandria Real Estate Equities in a report released on Monday, August 11th. Zacks Research analyst R. Department now expects that the real estate investment trust will earn $2.30 per share for the quarter, down from their previous forecast of $2.31. The consensus estimate for Alexandria Real Estate Equities’ current full-year earnings is $9.32 per share. Zacks Research also issued estimates for Alexandria Real Estate Equities’ Q4 2025 earnings at $2.27 EPS, Q2 2026 earnings at $2.10 EPS, Q3 2026 earnings at $2.10 EPS, FY2026 earnings at $8.42 EPS, Q1 2027 earnings at $2.06 EPS, Q2 2027 earnings at $2.10 EPS and FY2027 earnings at $8.38 EPS. A number of other research analysts also recently weighed in on ARE. Baird R W dropped their price target on Alexandria Real Estate Equities from $129.00 to $102.00 in a research note on Thursday, June 12th. BNP Paribas Exane dropped their price target on Alexandria Real Estate Equities from $111.00 to $85.00 and set a \"neutral\" rating on the stock in a research note on Tuesday, April 29th. JMP Securities reaffirmed a \"market outperform\" rating and set a $130.00 price target on shares of Alexandria Real Estate Equities in a research note on Wednesday, April 30th. Citigroup dropped their price target on Alexandria Real Estate Equities from $110.00 to $74.00 in a research note on Monday, June 2nd. Finally, JPMorgan Chase & Co. dropped their price target on Alexandria Real Estate Equities from $117.00 to $95.00 and set a \"neutral\" rating on the stock in a research note on Tuesday, May 20th. Ten investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Alexandria Real Estate Equities currently has an average rating of \"Hold\" and an average target price of $97.17. Shares of Alexandria Real Estate Equities stock opened at $73.66 on Tuesday. Alexandria Real Estate Equities has a one year low of $67.37 and a one year high of $125.63. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.23 and a quick ratio of 0.23. The stock’s 50-day moving average is $75.54 and its 200 day moving average is $82.42. The firm has a market cap of $12.74 billion, a price-to-earnings ratio of -566.62, a PEG ratio of 6.05 and a beta of 1.24. Alexandria Real Estate Equities (NYSE:ARE – Get Free Report) last announced its earnings results on Monday, July 21st. The real estate investment trust reported $2.33 EPS for the quarter, beating the consensus estimate of $2.29 by $0.04. Alexandria Real Estate Equities had a negative return on equity of 0.05% and a negative net margin of 0.33%. The company had revenue of $737.28 million for the quarter, compared to analyst estimates of $748.02 million. During the same quarter in the prior year, the company earned $2.36 EPS. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. The business also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th were issued a $1.32 dividend. This represents a $5.28 dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date was Monday, June 30th. Alexandria Real Estate Equities’s dividend payout ratio (DPR) is currently -4,061.54%. A number of large investors have recently modified their holdings of the stock. XTX Topco Ltd increased its position in shares of Alexandria Real Estate Equities by 73.9% during the second quarter. XTX Topco Ltd now owns 24,662 shares of the real estate investment trust’s stock valued at $1,791,000 after acquiring an additional 10,482 shares during the last quarter. Steward Partners Investment Advisory LLC increased its position in shares of Alexandria Real Estate Equities by 9.5% during the second quarter. Steward Partners Investment Advisory LLC now owns 4,130 shares of the real estate investment trust’s stock valued at $300,000 after acquiring an additional 358 shares during the last quarter. Lasalle Investment Management Securities LLC increased its position in shares of Alexandria Real Estate Equities by 89.2% during the second quarter. Lasalle Investment Management Securities LLC now owns 1,175,406 shares of the real estate investment trust’s stock valued at $85,370,000 after acquiring an additional 554,236 shares during the last quarter. Coldstream Capital Management Inc. increased its position in shares of Alexandria Real Estate Equities by 77.2% during the second quarter. Coldstream Capital Management Inc. now owns 4,530 shares of the real estate investment trust’s stock valued at $329,000 after acquiring an additional 1,974 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Alexandria Real Estate Equities by 4.9% during the second quarter. Charles Schwab Investment Management Inc. now owns 2,655,204 shares of the real estate investment trust’s stock valued at $192,848,000 after acquiring an additional 125,020 shares during the last quarter. Institutional investors own 96.54% of the company’s stock. Alexandria Real Estate Equities, Inc (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since our founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.

Zacks Research Issues Negative Outlook for ARE Earnings

Zacks Research lowered its earnings per share (EPS) estimates for Alexandria Real Estate Equities (ARE) for Q3 2025 to $2.30, down from $2.31, and revised full-year 2025 EPS to $9.32. The firm also projected Q4 2025 EPS at $2.27 and full-year 2026 EPS at $8.42. Other analysts, including Baird, BNP Paribas Exane, Citigroup, and JPMorgan Chase & Co., reduced price targets on ARE, with the average target price now at $97.17 and a consensus rating of 'Hold'. The company reported Q2 2025 earnings of $2.33 EPS, exceeding estimates, but recorded a negative return on equity and net margin. Revenue was $737.28 million, down 0.6% year-over-year. The company paid a $1.32 quarterly dividend, resulting in an annualized dividend of $5.28 and a 7.2% yield, with a negative dividend payout ratio of -4,061.54%. Several institutional investors increased their holdings during the second quarter, including XTX Topco Ltd, Steward Partners, Lasalle Investment Management, Coldstream Capital, and Charles Schwab. ARE is a life science REIT with operations in major innovation clusters such as Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.